Plasmid DNA forms the genetic foundation for many therapeutic strategies. The growth of cell and gene therapies, as well as the rapid emergence of the mRNA vaccine market, has created intense pressure for manufacturing of cGMP plasmid DNA. Thermo Fisher Scientific has responded to the call by expanding capacity and service offerings, in Carlsbad, California and in partnership with Arranta Bio, in Watertown, Massachusetts, so you can get to market faster.
Through our partnership with Arranta Bio, the Watertown, MA site is a commercial-ready manufacturing facility with process development, QC laboratories, and GMP plasmid manufacturing for raw material use or drug substances.
Learn more about the capabilities at this site by downloading our complete Site Fact Sheet.
Site Fact Sheet
Download the complete site capabilities fact sheet for this location.
Contact us for more information about this site.